Vaniqa is the only topical prescription treatment that slows the growth of facial hair. Topical eflornithine works on the root, inhibiting hair growth. Specifically, it inhibits the effect of the enzyme ornithine decarboxylase, which is essential for the synthesis of polyamines. Without polyamines, hair cannot grow.
Vaniqa works locally at the hair root, inhibiting the synthesis of polyamines to reduce facial hair growth
(Malhotra 2001)
Vaniqa is proven effective as monotherapy. However, due to its unique mechanism of action, Vaniqa can also be used in combination with all other treatment options to enhance their effectiveness. Vaniqa can slow hair growth and may reduce the frequency of the need for hair removal by other means (Shapiro 2005).
Treatment Option | Compatible with Vaniqa | |
| Plucking | ![]() |
|
| Waxing | ![]() |
|
| Depilatories | ![]() |
|
| Shaving | ![]() |
|
| Electrolysis | ![]() |
|
| Laser and Intense Pulsed Light (IPL) | ![]() |
|
| Anti-androgens and oral contraceptives | ![]() |
![]() | Non-hormonal treatment |
![]() | Combination therapy |
![]() | Vaniqa is a non-hormonal, non-systemic treatment |
![]() | Specifically and irreversibly inhibits the action of ornithine decarboxylase |
![]() | Vaniqa inhibits the synthesis of polyamines, reducing facial hair growth (Malhotra 2001) |
![]() | Vaniqa can be used in combination with all other treatment options |
